AI Won’t Lift Human Productivity Without Learning, New Pearson Research Finds
Pairing AI with skilling could add up to $6.6T to the U.S. economy by 2034 and deliver the return on investment businesses want DAVOS, Switzerland, Jan. 19, 2026... Read more.
GCL SI Delivers Marine Floating Solar Solution in the Maldives, Enabling Island Energy Transition
SUZHOU, China, Jan. 19, 2026 /PRNewswire/ — GCL System Integration (GCL SI) has announced the successful completion of the joint floating solar energy project... Read more.
ZBXCX Moves Forward With European Expansion in 2026
IOWA CITY, Iowa, Jan. 19, 2026 /PRNewswire/ — ZBXCX Digital Asset Exchange has announced its plans to further advance its expansion into the European market... Read more.
Huyett’s Swiss Lathes Meet Custom and Precision Manufacturing Needs
Consolidate your supply chain, buy custom metal components, and receive in-house manufacturing support solutions with Huyett. MINNEAPOLIS, Kan., Jan. 19, 2026 /PRNewswire/... Read more.
IBM Study: AI Poised to Drive Smarter Business Growth Through 2030
By 2030, surveyed executives anticipate AI spend to shift from efficiency to innovation AI productivity gains projected to increase by 42%, fueling reinvestment... Read more.
Chassis Supply Chain’s “iPhone Moment”: China’s Tier 1 Shift as LeeKr Emerges
SHANGHAI, Jan. 19, 2026 /PRNewswire/ — Over the past decade, China’s electric vehicle (EV) industry has evolved from a niche experiment into a leading... Read more.
D3 Bio Receives U.S. FDA Clearance for Two IND Applications, Enabling Phase 1 Trial of D3S‑003 and Phase 2 Combination Study of Elisrasib (D3S‑001) with D3S‑002
SHANGHAI, Jan. 18, 2026 /PRNewswire/ — D3 Bio, a global clinical‑stage biotechnology company focused on developing transformative oncology therapeutics,... Read more.
AbelZeta Announces Remaining China Rights to GPC3 Armored CAR-T Therapy to be Acquired by AstraZeneca
ROCKVILLE, Md. and SHANGHAI, Jan. 18, 2026 /PRNewswire/ — AbelZeta Pharma, Inc. (“AbelZeta”), a global clinical-stage biopharmaceutical company... Read more.
Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Jan. 18, 2026 /PRNewswire/ — Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed... Read more.
WuXi AppTec Receives Double “A” Rating from CDP for Climate Change and Water Security Leadership
SHANGHAI, Jan. 18, 2026 /PRNewswire/ — WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization),... Read more.